Public Profile

Aventis Inc.

Aventis Inc., a prominent player in the biotechnology and pharmaceutical industry, is headquartered in the United States. Founded in the early 2000s, the company has established itself as a leader in innovative drug development and biopharmaceutical solutions, with a strong operational presence across North America and Europe. Specialising in cutting-edge therapies for chronic diseases, Aventis Inc. is renowned for its unique approach to personalised medicine, which sets it apart from competitors. The company has achieved significant milestones, including the successful launch of several groundbreaking treatments that have transformed patient care. With a commitment to research and development, Aventis Inc. continues to enhance its market position, earning accolades for its contributions to healthcare and its dedication to improving patient outcomes.

DitchCarbon Score

How does Aventis Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

55

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Aventis Inc.'s score of 55 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Aventis Inc.'s reported carbon emissions

Aventis Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor do they have specified reduction targets or commitments outlined in their climate initiatives. Without specific emissions figures or reduction goals, it is challenging to assess their climate impact or commitments in detail. However, the absence of data may indicate a need for further transparency in their environmental strategies. As the industry increasingly prioritises sustainability, it is essential for companies like Aventis Inc. to establish clear climate commitments and measurable targets to align with global efforts in reducing carbon emissions.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Aventis Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Aventis Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Aventis Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Genentech USA, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Germed Farmacêutica Ltda.

BR
Pharmaceutical Preparation Manufacturing
Updated 2 days ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers